Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain Medical Dialogues Bureau29 Sep 2019 4:25 AM GMTProclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...